Neurona Therapeutics

NTE001 Study – A Phase I/II Clinical Trial of NRTX-1001 Nerve Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy

NTE002 Study – A Phase I/II Clinical Trial of NRTX-1001 Inhibitory Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy

Neurona is developing off-the-shelf, allogeneic neuronal, glial, and gene-edited neural cell therapies for single-dose targeted repair of the nervous system.

Events for Neurona Therapeutics; a clinical-stage company focused on discovering and developing allogeneic neural cell therapies to treat chronic diseases of the nervous system.

Select Articles for Neurona Therapeutics; a clinical-stage company focused on discovering and developing allogeneic neural cell therapies to treat chronic diseases of the nervous system.

Latest News and Events for Neurona Therapeutics; a clinical-stage company focused on discovering and developing allogeneic neural cell therapies to treat chronic diseases of the nervous system.

Press Releases for Neurona Therapeutics; a clinical-stage company focused on discovering and developing allogeneic neural cell therapies to treat chronic diseases of the nervous system.

The company is committed to offering compensation and benefits that support employees’ needs and well-being as they focus on shared goals for patients.

The company seeks self-motivated individuals who have demonstrated a passion for scientific research.

The company aims to create regenerative cell therapies with the potential to improve quality of life for people with chronic neurologic disorders.

Neurona’s Visiting Scientist and Summer Diversity Internship Programs provides the opportunity to conduct research and to help build novel cell therapies for neurological disorders.

Neurona Therapeutics is a clinical-stage company focused on discovering and developing allogeneic neural cell therapies to treat chronic diseases of the nervous system.

Neurona Therapeutics is developing cell therapies for targeted repair of dysfunctional neural circuits underlying chronic diseases

Neurona is developing cell therapies for targeted repair of dysfunctional neural circuits underlying chronic diseases

Privacy Policy for the Neurona website. Neurona is a clinical-stage company focused on discovering and developing allogeneic neural cell therapies to treat chronic diseases of the nervous system.

Terms of Use for the Neurona website. Neurona is a clinical-stage company focused on discovering and developing allogeneic neural cell therapies to treat chronic diseases of the nervous system.